Cardiovascular risk associated with HIV therapy

被引:23
作者
Currier, JS [1 ]
机构
[1] Univ Calif Los Angeles, Ctr AIDS Res & Educ, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/00126334-200209011-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S16 / S23
页数:8
相关论文
共 24 条
[1]  
CAHN P, 2001, 1 INT AIDS SOC C HIV
[2]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[3]  
CURRIER JS, 2000, 7 C RETR OPP INF SAN
[4]   Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy [J].
Depairon, M ;
Chessex, S ;
Sudre, P ;
Rodondi, N ;
Doser, N ;
Chave, JP ;
Riesen, W ;
Nicod, P ;
Darioli, R ;
Telenti, A ;
Mooser, V .
AIDS, 2001, 15 (03) :329-334
[5]  
Dubé MP, 2000, CLIN INFECT DIS, V31, P1216
[6]   Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy [J].
Frost, PH ;
Havel, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :26B-31B
[7]   Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology [J].
Grundy, SM ;
Pasternak, R ;
Greenland, P ;
Smith, S ;
Fuster, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1348-1359
[8]   Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities [J].
Henry, K ;
Melroe, H ;
Huebesch, J ;
Hermundson, J ;
Simpson, J .
LANCET, 1998, 352 (9133) :1031-1032
[9]  
HOLMBERG S, 2002, 9 C RETR OPP INF SES
[10]  
KLEIN D, 1999, 6 C RETR OPP INF CHI